|
Hirasawa, 2018 [14]
|
45/45
|
No complication including surgical site infection, wound complications, prolonged numbness or weakness, or allergy to the medication
|
No difference
|
|
Ban WR,2017 [5]
|
43/43
|
No mention
|
N/A
|
|
Villatte, 2016 [6]
|
75/75
|
Wound septic complication (2 hips, treatment group)
|
No difference
|
|
Hofstad, 2015 [10]
|
55/54
|
No mention
|
N/A
|
|
den Hartog, 2015 [11]
|
25/25
|
Dizziness, hypotension and retention of urine
|
No difference
|
|
Zoric, 2014 [12]
|
29/29
|
Nausea and vomiting
|
No difference
|
|
Dobie, 2012 [15]
|
46/46
|
Hypotension, chest pain, dural leak
|
No difference
|
|
Murphy, 2012 [7]
|
45/46
|
Urinary retention
|
No difference
|
|
Andersen, 2011 [16]
|
12/12
|
No clinical side effect, including cardiac and hemodynamic changes
|
No difference
|
|
Lunn, 2011 [13]
|
60/60
|
Quadriceps muscle palsy
|
No difference
|
|
Liu, 2011 [8]
|
40/40
|
Hemodynamic change, nausea and vomiting, urinary retention, respiratory depression, rash, and deep vein thrombosis
|
No difference
|
|
Busch, 2010 [9]
|
32/31
|
Wound blister, prominent suture trimming and deep vein thrombosis (4 hips, 3 in the treatment group and 1 in the control group)
|
No difference
|
